Christopher M. Allan

819 total citations
17 papers, 486 citations indexed

About

Christopher M. Allan is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Cell Biology. According to data from OpenAlex, Christopher M. Allan has authored 17 papers receiving a total of 486 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Cardiology and Cardiovascular Medicine, 7 papers in Molecular Biology and 6 papers in Cell Biology. Recurrent topics in Christopher M. Allan's work include Lipid metabolism and disorders (12 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (5 papers) and Coenzyme Q10 studies and effects (4 papers). Christopher M. Allan is often cited by papers focused on Lipid metabolism and disorders (12 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (5 papers) and Coenzyme Q10 studies and effects (4 papers). Christopher M. Allan collaborates with scholars based in United States, Denmark and Australia. Christopher M. Allan's co-authors include Loren G. Fong, Anne P. Beigneux, Stephen G. Young, Cuiwen He, Michael Ploug, Rachel S. Jung, Catherine F. Clarke, UyenPhuong Tran, Mikael Larsson and Letian Xie and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Cell Metabolism and The FASEB Journal.

In The Last Decade

Christopher M. Allan

17 papers receiving 483 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Christopher M. Allan United States 11 252 211 176 84 81 17 486
Line M. Grønning-Wang Norway 9 56 0.2× 330 1.6× 37 0.2× 26 0.3× 48 0.6× 10 449
Dipsikha Biswas Canada 11 57 0.2× 289 1.4× 38 0.2× 34 0.4× 80 1.0× 17 450
J Nikazy United States 9 244 1.0× 181 0.9× 240 1.4× 149 1.8× 74 0.9× 11 494
Jackie Bodnar United States 6 63 0.3× 385 1.8× 71 0.4× 53 0.6× 123 1.5× 7 545
Roger Hoi-Fung Wong United States 6 43 0.2× 343 1.6× 35 0.2× 77 0.9× 48 0.6× 8 595
Victoria R. Cook United States 12 125 0.5× 221 1.0× 196 1.1× 57 0.7× 57 0.7× 14 518
Chastity L. Healy United States 8 160 0.6× 214 1.0× 41 0.2× 67 0.8× 23 0.3× 16 419
Mari Odashima Japan 6 169 0.7× 324 1.5× 29 0.2× 6 0.1× 201 2.5× 7 538
Thomas J. Wheeler United States 11 41 0.2× 241 1.1× 41 0.2× 30 0.4× 48 0.6× 24 357
Andrii Boguslavskyi United Kingdom 10 188 0.7× 265 1.3× 23 0.1× 13 0.2× 31 0.4× 13 431

Countries citing papers authored by Christopher M. Allan

Since Specialization
Citations

This map shows the geographic impact of Christopher M. Allan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher M. Allan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher M. Allan more than expected).

Fields of papers citing papers by Christopher M. Allan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher M. Allan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher M. Allan. The network helps show where Christopher M. Allan may publish in the future.

Co-authorship network of co-authors of Christopher M. Allan

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher M. Allan. A scholar is included among the top collaborators of Christopher M. Allan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher M. Allan. Christopher M. Allan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Luz, J.G., Anne P. Beigneux, Cuiwen He, et al.. (2020). The structural basis for monoclonal antibody 5D2 binding to the tryptophan-rich loop of lipoprotein lipase. Journal of Lipid Research. 61(10). 1347–1359. 8 indexed citations
2.
Young, Stephen G., Loren G. Fong, Anne P. Beigneux, et al.. (2019). GPIHBP1 and Lipoprotein Lipase, Partners in Plasma Triglyceride Metabolism. Cell Metabolism. 30(1). 51–65. 101 indexed citations
3.
Beigneux, Anne P., Christopher M. Allan, Norma P. Sandoval, et al.. (2019). Lipoprotein lipase is active as a monomer. Proceedings of the National Academy of Sciences. 116(13). 6319–6328. 62 indexed citations
4.
Allan, Christopher M., Patrick J. Heizer, Yiping Tu, et al.. (2018). Impaired thermogenesis and sharp increases in plasma triglyceride levels in GPIHBP1-deficient mice during cold exposure. Journal of Lipid Research. 59(4). 706–713. 10 indexed citations
5.
He, Cuiwen, Thomas A. Weston, Rachel S. Jung, et al.. (2018). NanoSIMS Analysis of Intravascular Lipolysis and Lipid Movement across Capillaries and into Cardiomyocytes. Cell Metabolism. 27(5). 1055–1066.e3. 42 indexed citations
6.
Allan, Christopher M., Patrick J. Heizer, Yiping Tu, et al.. (2018). An upstream enhancer regulates Gpihbp1 expression in a tissue-specific manner. Journal of Lipid Research. 60(4). 869–879. 6 indexed citations
7.
Bradley, Michelle C., et al.. (2018). Characterization of Coq11, a novel protein involved in the biosynthesis of coenzyme Q in Saccharomyces cerevisiae. The FASEB Journal. 32(S1). 1 indexed citations
8.
He, Cuiwen, Xuchen Hu, Rachel S. Jung, et al.. (2017). Lipoprotein lipase reaches the capillary lumen in chickens despite an apparent absence of GPIHBP1. JCI Insight. 2(20). 7 indexed citations
9.
He, Cuiwen, et al.. (2017). Human COQ9 Rescues a coq9 Yeast Mutant by Enhancing Coenzyme Q Biosynthesis from 4-Hydroxybenzoic Acid and Stabilizing the CoQ-Synthome. Frontiers in Physiology. 8. 463–463. 12 indexed citations
10.
Allan, Christopher M., Mikael Larsson, Patrick J. Heizer, et al.. (2017). Mutating a conserved cysteine in GPIHBP1 reduces amounts of GPIHBP1 in capillaries and abolishes LPL binding. Journal of Lipid Research. 58(7). 1453–1461. 13 indexed citations
11.
Larsson, Mikael, Christopher M. Allan, Rachel S. Jung, et al.. (2017). Apolipoprotein C-III inhibits triglyceride hydrolysis by GPIHBP1-bound LPL. Journal of Lipid Research. 58(9). 1893–1902. 43 indexed citations
12.
Allan, Christopher M., Mikael Larsson, Rachel S. Jung, et al.. (2016). Mobility of “HSPG-bound” LPL explains how LPL is able to reach GPIHBP1 on capillaries. Journal of Lipid Research. 58(1). 216–225. 36 indexed citations
13.
Allan, Christopher M., Mikael Larsson, Xuchen Hu, et al.. (2016). An LPL–specific monoclonal antibody, 88B8, that abolishes the binding of LPL to GPIHBP1. Journal of Lipid Research. 57(10). 1889–1898. 9 indexed citations
14.
Hu, Xuchen, Mark W. Sleeman, Kazuya Miyashita, et al.. (2016). Monoclonal antibodies that bind to the Ly6 domain of GPIHBP1 abolish the binding of LPL. Journal of Lipid Research. 58(1). 208–215. 14 indexed citations
15.
Allan, Christopher M., Shiri Procaccia, Yiping Tu, et al.. (2015). Palmoplantar Keratoderma in Slurp2-Deficient Mice. Journal of Investigative Dermatology. 136(2). 436–443. 14 indexed citations
16.
He, Cuiwen, Letian Xie, Christopher M. Allan, UyenPhuong Tran, & Catherine F. Clarke. (2014). Coenzyme Q supplementation or over-expression of the yeast Coq8 putative kinase stabilizes multi-subunit Coq polypeptide complexes in yeast coq null mutants. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 1841(4). 630–644. 74 indexed citations
17.
Allan, Christopher M., Ryoichi Saiki, Wei‐Siang Liau, et al.. (2012). A conserved START domain coenzyme Q-binding polypeptide is required for efficient Q biosynthesis, respiratory electron transport, and antioxidant function in Saccharomyces cerevisiae. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 1831(4). 776–791. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026